AMPLITUDE (BRCA1/2-mutated metastatic hormone-sensitive prostate cancer) niraparib + abiraterone + ADT (ongoing study) | Dr Dilanka De Silva
Who should read this? People with newly diagnosed metastatic hormone-sensitive prostate cancer who carry a BRCA1 or BRCA2 mutation (in […]